news 2022

« BACK

Health



Results 21 - 40 of 1757.


Health - Life Sciences - 20.12.2022
New gene mutation discovered in children in obesity research
New gene mutation discovered in children in obesity research
A research team at the University of Leipzig Medical School has discovered a new mechanism associated with severe childhood obesity. A genetic alteration leads to an unusual expression of a gene related to the control of the feeling of hunger. Until now, this alteration has not been detected with general genetic diagnostics in obesity.

Health - 20.12.2022
Less infectious particles from children's lungs
Less infectious particles from children’s lungs
A comprehensive analysis on particle exhalation in adults and children Children exhale significantly fewer potentially infectious particles than adults - at least this is true for the small respiratory droplets that are predominantly produced in the lungs. This is a key finding of a study conducted by the Max Planck Institutes for Dynamics and Self-Organization and for Chemistry in collaboration with the University Göttingen Medical Center.

Health - Computer Science - 20.12.2022
7 times our researchers engineered with impact
7 times our researchers engineered with impact
From biomedical engineering and quantum hardware through to wave modelling and computer science, here are seven times in 2022 that our researchers led impactful research. Spray coating developed to shield surfaces from viruses, bacteria A first-of-its-kind sprayable coating that can prevent the surface spread of infection from bacteria and viruses, including COVID-19, over a sustained period has been developed by a team of Australian researchers including Professor Antonio Tricoli from School of Biomedical Engineering.

Health - Life Sciences - 20.12.2022
New gene mutation in children
New gene mutation in children
A research team at Leipzig University's Faculty of Medicine has discovered a new mechanism that is associated with severe obesity in children. This genetic rearrangement leads to an unusual expression of a gene involved in hunger control and is not detected by most routine genetic tests for obesity.

Health - Pharmacology - 19.12.2022
First-line defences against COVID-19 are short-lived and may explain reinfection
A new study finds that antibodies produced in the nose decline 9 months after infection, while those found in the blood last at least a year. A new study finds that antibodies produced in the nose decline nine months after COVID-19 infection, while antibodies found in the blood last at least a year.

Life Sciences - Health - 19.12.2022
How does the same DNA result in more than 200 different cell types?
How does the same DNA result in more than 200 different cell types?
Every human body starts out as one single cell: a fertilized egg. This cell develops into all kinds of cell types: skin cells, liver cells, blood cells. Although these cell types look and function differently, they all contain exactly the same DNA. Tuncay Baubec and his research group try to understand how the same genetic code is used to build the more than 200 different cell types in our body.

Health - Pharmacology - 19.12.2022
New approach in the battle against malaria
New research by a team of UT researchers could provide a promising approach in the battle against malaria. In the research published in the scientific journal ACS Infectious Diseases , the researchers combat the malaria parasite in mosquitoes in a specific phase of their life. "It's a unique approach: previous research focused predominantly on treatment in humans." Malaria is a major health problem all over the world.

Health - Social Sciences - 19.12.2022
Green social prescribing: time in nature can increase wellbeing
Nature is a powerful tool that can be harnessed by social prescribers to improve people's health and wellbeing, according to a series of new evidence reviews led by a UCL researcher.

Health - Pharmacology - 19.12.2022
Relationship between high-dose statin therapy and risk of osteoporosis confirmed in mouse models
Using several million medical records, a research group from MedUni Vienna and the Complexity Science Hub (CSH) showed that there was a correlation between the dosage of statins and the diagnosis of osteoporosis as early as 2019. This finding has now been confirmed in a preclinical study, which was recently published in the journal Biomedicine and Pharmacotherapy.

Pharmacology - Health - 19.12.2022
Technique for tracking resistant cancer cells could lead to new treatments for relapsing breast cancer patients
Technique for tracking resistant cancer cells could lead to new treatments for relapsing breast cancer patients
Cambridge scientists have managed to identify and kill those breast cancer cells that evade standard treatments in a study in mice. The approach is a step towards the development of new treatments to prevent relapse in patients. Tumours are incredibly complex, made up of many different types of tumour cells - and some of these cells are able to evade standard cancer treatments Kirsty Sawicka Tumours are complex entities made up of many types of cells, including cancer cells and normal cells.

Life Sciences - Health - 19.12.2022
New findings on memory impairment in epilepsy
New findings on memory impairment in epilepsy
Study by the University of Bonn elucidates a potential mechanism People with chronic epilepsy often experience impaired memory. Researchers at the University of Bonn have now found a mechanism in mice that could explain these deficits. The German Center for Neurodegenerative Diseases (DZNE) was also involved in the study.

Life Sciences - Health - 19.12.2022
Stranded dolphins’ brains show common signs of Alzheimer’s disease
The brains of three different species of stranded dolphins show classic markers of human Alzheimer's disease, according to the most extensive study into dementia in odontocetes (toothed whales). The new pan-Scotland research, a collaboration between the University of Glasgow, the Universities of St Andrews and Edinburgh and the Moredun Research Institute, studied the brains of 22 odontocetes which had all been stranded in Scottish coastal waters.

Innovation - Health - 19.12.2022
Aliper Therapeutics, a spinoff of the IOR, wins the Boldbrain Startup Challenge
The national jury of the fifth edition of the Boldbrain Startup Challenge awarded first prize to Aliper Therapeutics, a spin-off of the USI-affiliated Institute of Oncology Research (IOR) in Bellinzona. We talked about it with Nicolò Pernigoni, postdoc at the IOR. This is, together with BigOmics Analytics SA and MV BioTherapeutics, the third start-up from the IOR and the Institute for Research in Biomedicine (IRB) to be awarded a prize by Boldbrain, demonstrating the quality and potential of the research conducted in the two affiliated institutes.

Life Sciences - Health - 19.12.2022
Scientists tackle rusty plant threat
Scientists tackle rusty plant threat
University of Queensland scientists have developed an environmentally friendly RNA-based spray to help combat myrtle rust, which has wiped out many Australian plants. Developed in collaboration with Department of Agriculture and Fisheries forest pathologists, the spray induces RNA interference (RNAi) - a natural way to shut down protein translation - which means it could stop the spread of myrtle rust through bushland, home gardens and nurseries.

Health - 19.12.2022
Under attack: Researchers shed light on how Lyme disease infects the body
Under attack: Researchers shed light on how Lyme disease infects the body
The findings could better inform treatment options and help prevent severe outcomes of the disease An estimated 476,000 Americans are infected each year with Lyme disease, a condition causing a wide range of symptoms that include fever, rash, and joint pain, as well as effects on the central nervous system and heart.

Health - Pharmacology - 19.12.2022
Global study presents first results on the longer-term effects of therapies for the treatment of critically ill patients with COVID-19
Global study presents first results on the longer-term effects of therapies for the treatment of critically ill patients with COVID-19
Published today in The Journal of the American Medical Association ( JAMA ), the study is part of the ongoing Randomized Embedded Multifactorial Adaptive Platform for Community Acquired Pneumonia (REMAP-CAP) trial and was led by Monash University's Dr Lisa Higgins from the School of Public Health and Preventive Medicine.

Health - 19.12.2022
Researchers identify ’born to be bad’ colorectal cancer tumours
An international research team has identified 'born to be bad' colorectal tumours in people with early stage cancer, which could help medical experts pinpoint and better treat aggressive tumours. The team from Monash University , CRUK Beatson Institute in Glasgow and Queens University in Belfast found a feature of early-stage colorectal tumours in mice and humans, known as TGF? signalling, that is active in tumour cells and is profoundly tumour-promoting.

Life Sciences - Health - 16.12.2022
UCLA-developed soft brain probe could be a boon for depression research
The probe is flexible enough to monitor the brains of research subjects as they move and perform everyday activities. The ability to continuously measure neurotransmitters would improve our understanding of how these chemicals affect psychological states. Anyone familiar with antidepressants like Prozac or Wellbutrin knows that these drugs boost levels of neurotransmitters in the brain like serotonin and dopamine, which are known to play an important role in mood and behavior.

Health - Life Sciences - 16.12.2022
The parasite that is the most frequent cause of a type of meningitis, found for the first time in rats from continental Europe
A research conducted by the Parasites and Health group of the University of Valencia has found for the first time in continental Europe the nematode worm) Angiostrongylus cantonensis , a zoonotic (capable of being transmitted to humans) parasite present in the pulmonary arteries of rats and that it is the most common causative agent in humans of eosinophilic meningitis (EM).

Health - Life Sciences - 16.12.2022
A ’muscular’ response to regeneration
Therapies to target neuromuscular disorders affecting million of people worldwide are on the horizon thanks to research at the Montreal Clinical Research Institute of Montreal. CONTENU - Neuromuscular disorders affect millions of people worldwide. Now a discovery made at the Montreal Clinical Research Institute of Montreal (IRCM) opens the door to the development of targeted therapies.